Leidos director receives stock, option awards
Leidos Holdings director Harry M. Jansen Kraemer Jr. reported new equity awards in the company.
Rhea-AI Filing Summary
Leidos Holdings director Harry M. Jansen Kraemer Jr. reported new equity awards in the company. He received 1,067 shares of Common Stock indirectly through the Key Executive Stock Deferral Plan, recorded as an acquisition rather than an open-market purchase.
He was also granted 1,281 stock options with a $131.26 exercise price, each convertible into one share of common stock. According to the award terms, the option vests in full on the earlier of the first anniversary of the grant date or the conclusion of the next annual stockholders’ meeting.
Following these transactions, Kraemer holds 93,281 shares of Common Stock directly and 130,472.1669 shares indirectly through the deferral plan, along with the newly granted 1,281 stock options.
Positive
- None.
Negative
- None.
Insider Trade Summary
Grant/Award: 2,348 shares
Grant/Award
3 txns
Insider
KRAEMER HARRY M JANSEN JR
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) | 1,281 | $0.00 | $0.00 |
| Grant/Award | Common Stock | 1,067 | $0.00 | $0.00 |
| holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Stock Option (Right to Buy) — 1,281 contracts (Direct);
Common Stock — 130,472.1669 shares (Indirect, By Key Executive Stock Deferral Plan);
Common Stock — 93,281 shares (Direct)
Footnotes (1)
- F1. The option shall vest and become exercisable in full on the earlier of (i) the first anniversary of the Grant Date, or (ii) the date that the next annual meeting of the stockholders of the Company is concluded.
Key Figures
Common shares granted (indirect): 1,067 shares
Stock options granted: 1,281 options at $131.26
Option expiration date: May 7, 2033
+3 more
6 metrics
Common shares granted (indirect)
1,067 shares
Award via Key Executive Stock Deferral Plan on May 8, 2026
Stock options granted
1,281 options at $131.26
Option grant on May 8, 2026, exercise price per share
Option expiration date
May 7, 2033
Expiration of 1,281 stock options granted May 8, 2026
Direct common shares after transaction
93,281 shares
Direct holdings of Leidos common stock following reported awards
Indirect common shares after transaction
130,472.1669 shares
Held via Key Executive Stock Deferral Plan after awards
Options outstanding after grant
1,281 options
Stock Option (Right to Buy) position following transaction
Key Terms
Key Executive Stock Deferral Plan, Stock Option (Right to Buy), Grant, award, or other acquisition, exercise price, +1 more
5 terms
Key Executive Stock Deferral Plan financial
"nature_of_ownership: "By Key Executive Stock Deferral Plan""
Stock Option (Right to Buy) financial
"security_title: "Stock Option (Right to Buy)""
Grant, award, or other acquisition financial
"transaction_code_description: "Grant, award, or other acquisition""
exercise price financial
"conversion_or_exercise_price: "131.2600" per share"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
vest and become exercisable financial
"The option shall vest and become exercisable in full on the earlier of..."
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Leidos (LDOS) director Harry Kraemer acquire in this Form 4?
Leidos director Harry M. Jansen Kraemer Jr. received equity awards, not open-market purchases. He acquired 1,067 common shares via the Key Executive Stock Deferral Plan and 1,281 stock options, both recorded as compensation-related grants under transaction code A.
What are the terms of Harry Kraemer’s new Leidos (LDOS) stock options?
Kraemer’s new Leidos stock options cover 1,281 shares at a $131.26 exercise price. The options vest in full on the earlier of the first anniversary of the grant date or the conclusion of the next annual stockholders’ meeting, and expire on May 7, 2033.
Is the Leidos (LDOS) Form 4 transaction a market buy or a compensation grant?
The Form 4 reflects compensation grants, not market buys. Both the 1,067 common shares and 1,281 stock options are coded A, described as a grant, award, or other acquisition, indicating they were issued as part of Leidos’ executive compensation arrangements.
How is indirect ownership reported for Leidos (LDOS) director Harry Kraemer?
Indirect ownership is reported through the Key Executive Stock Deferral Plan. Kraemer is shown holding 130,472.1669 Leidos common shares indirectly, with the nature of ownership specifically labeled as “By Key Executive Stock Deferral Plan” in the Form 4 disclosure.
AI-generated analysis. How Rhea-AI works. Not financial advice.
